☆ 4.6 Review

Drug-Eluting Stents: Technical and Clinical Progress

BIOMIMETICS (2023)

Related references

Note: Only part of the references are listed.

Article Cardiac & Cardiovascular Systems

Comparison of long-term clinical outcomes among zotarolimus-, everolimus-, and biolimus-eluting stents in acute myocardial infarction patients with renal impairment

Seok Oh et al.

Summary: This study evaluated the outcomes of different drug-eluting stents (DESs) in acute myocardial infarction (AMI) patients with renal impairment. The results showed no significant difference between EES, ZES, and BES in terms of major adverse cardiac and cerebrovascular events, except for non-fatal MI.

CARDIOLOGY JOURNAL (2023)

Add to Collection

Review Cardiac & Cardiovascular Systems

Evolution of drug-eluting coronary stents: a back-and-forth journey from the bench to bedside

Johny Nicolas et al.

Summary: Coronary stents have revolutionized the treatment of coronary artery disease. The introduction of new-generation drug-eluting stents has greatly improved the safety and efficacy compared to bare-metal stents. There are now over 20 different DES types available, each with its unique features and characteristics. The clinical implications of stent design in high-risk subsets of patients are also discussed.

CARDIOVASCULAR RESEARCH (2023)

Add to Collection

Review Pharmacology & Pharmacy

Drug-eluting stents for the treatment of coronary artery disease: A review of recent advances

Sung-Jin Hong et al.

Summary: This article reviewed the recent advances in drug-eluting stent technologies for the treatment of coronary artery disease and discussed the need for further improvements in patient survival and clinical outcomes. The use of different drugs or drug combinations with various actions and technological refinement in manufacturing were suggested as potential areas for development. Additionally, strategies to reduce clinical bleeding, such as shortened duration of dual-antiplatelet therapy, were mentioned as ongoing progress in post-stent antiplatelet therapy.

EXPERT OPINION ON DRUG DELIVERY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Bioresorbable stents: Is the game over?

Emanuele Gallinoro et al.

Summary: Bioresorbable scaffolds were developed as an alternative to conventional stents to avoid the harmful effects of permanent metallic structures. However, studies have raised concerns about the safety and efficacy of these scaffolds compared to drug-eluting stents. Ongoing research is focused on improving the design and performance of bioresorbable scaffolds.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Evolutionary perspective of drug eluting stents: from thick polymer to polymer free approach

Sadia Hassan et al.

Summary: The evolution of drug eluting stents (DES) from the first generation to the third generation has seen a transition from thick polymeric coatings to thin coatings, ultimately leading to the development of polymer-free DES. This advancement highlights the continuous improvement in stent technology in the medical industry.

JOURNAL OF CARDIOTHORACIC SURGERY (2022)

Add to Collection

Article Biology

In Stent Neo-Atherosclerosis: Pathophysiology, Clinical Implications, Prevention, and Therapeutic Approaches

Annunziata Nusca et al.

Summary: Despite the improvements in revascularization therapies, a significant number of patients treated with PCI still experience stent failure due to neo-atherosclerosis (NA). This can lead to late in-stent restenosis and stent thrombosis, affecting long-term clinical outcomes. Intra-coronary imaging techniques are crucial for early detection of NA, which has distinct pathophysiological mechanisms and requires tailored prevention and treatment strategies.

LIFE-BASEL (2022)

Add to Collection

Review Peripheral Vascular Disease

Recent Advances in Stent Technology: Do They Reduce Cardiovascular Events?

Allen J. Weiss et al.

Summary: Drug-eluting stents are widely used in coronary revascularization and have been proven to be superior to other treatments. The design of these stents is constantly improving to enhance clinical outcomes and safety. The incorporation of bioresorbable polymers or ultrathin struts in newer designs has shown promising results in terms of safety and efficacy.

CURRENT ATHEROSCLEROSIS REPORTS (2022)

Add to Collection

Review Cardiac & Cardiovascular Systems

Coronary In-Stent Restenosis JACC State-of-the-Art Review

Gennaro Giustino et al.

Summary: Drug-eluting stent technologies have greatly improved the effectiveness and safety of percutaneous coronary interventions. However, in-stent restenosis (ISR) remains a significant public health concern. This paper comprehensively reviews the incidence, mechanisms, and imaging characteristics of ISR, and proposes a contemporary treatment algorithm.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2022)

Add to Collection

Article Chemistry, Multidisciplinary

An intricate interplay between stent drug dose and release rate dictates arterial restenosis

Alistair McQueen et al.

Summary: Research indicates that the severity and time-course of restenosis are critically dependent on drug delivery strategy, and simply ramping up drug dose or prolonging drug release time is not sufficient to improve stent efficacy. Factors such as level of stent over-expansion and stent design features also influence restenosis development.

JOURNAL OF CONTROLLED RELEASE (2022)

Add to Collection

Review Health Care Sciences & Services

Ultrathin Struts Drug-Eluting Stents: A State-of-the-Art Review

Attilio Leone et al.

Summary: New-generation ultrathin strut drug-eluting stents (DESs) have become the standard of care for percutaneous coronary intervention (PCI). Compared to conventional new-generation DESs, ultrathin strut DESs have superior efficacy and safety in reducing target-lesion and target-vessel failures.

JOURNAL OF PERSONALIZED MEDICINE (2022)

Add to Collection

Article Cardiac & Cardiovascular Systems

A serial optical frequency-domain imaging study of early and late vascular responses to bioresorbable-polymer sirolimus-eluting stents for the treatment of acute myocardial infarction and stable coronary artery disease patients: results of the MECHANISM-ULTIMASTER study

Tomonori Itoh et al.

Summary: The study evaluated early and late vascular healing in response to bioresorbable-polymer sirolimus-eluting stents (BP-SES) for patients with ST-elevation myocardial infarction (STEMI) and stable coronary artery disease (CAD). Results showed significant improvements in strut coverage and healing processes in the early phase after BP-SES implantation, particularly in STEMI patients, with qualitatively and quantitatively consistent neointimal coverage achieved in both groups at 1 year.

CARDIOVASCULAR INTERVENTION AND THERAPEUTICS (2022)

Add to Collection

Review Engineering, Biomedical

Surface engineering at the nanoscale: A way forward to improve coronary stent efficacy

Aleena Mary Cherian et al.

Summary: Nanotechnology can enhance stent performance by modulating surface properties to improve compatibility and effectiveness with endothelial cells.

APL BIOENGINEERING (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Clinical outcomes of an ultrathin-strut sirolimus-eluting stent in all-comers population: Thailand Orsiro registry

Pannipa Suwannasom et al.

Summary: The study evaluated the clinical outcomes of Orsiro SES in a Thai population and confirmed the safety and efficacy of the ultrathin strut sirolimus-eluting stent in various high-risk subgroups. There were no significant differences in outcomes observed in pre-specified subgroups compared to the overall population.

BMC CARDIOVASCULAR DISORDERS (2021)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

The third generation of drug-eluting stents: Reassuring data while we wait for the next one COMMENT

Sergio Bravo Baptista

REVISTA PORTUGUESA DE CARDIOLOGIA (2021)

Add to Collection

Article Engineering, Biomedical

Significant difference between sirolimus and paclitaxel nanoparticles in anti-proliferation effect in normoxia and hypoxia: The basis of better selection of atherosclerosis treatment

Youlu Chen et al.

Summary: Through experimental exploration of the different mechanisms of action of sirolimus and paclitaxel in the treatment of vascular restenosis, it was found that sirolimus more effectively inhibits the proliferation of endothelial cells and smooth muscle cells under hypoxic conditions by inhibiting HIF-1α expression and glycolysis.

BIOACTIVE MATERIALS (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Thin Strut CoCr Biodegradable Polymer Biolimus A9-Eluting Stents versus Thicker Strut Stainless Steel Biodegradable Polymer Biolimus A9-Eluting Stents: Two-Year Clinical Outcomes

Ian B. A. Menown et al.

Summary: The 2-year follow-up data showed that the thin-strut CoCr-BP-BES was associated with improved clinical outcomes compared to the thick-strut SS-BP-BES, including lower rates of major adverse cardiac events and stent thrombosis.

JOURNAL OF INTERVENTIONAL CARDIOLOGY (2021)

Add to Collection

Article Medicine, General & Internal

Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk

Marco Valgimigli et al.

Summary: The study showed that one month of dual antiplatelet therapy was noninferior to continuing therapy for at least 2 additional months in terms of net adverse clinical events and major adverse cardiac or cerebral events in patients with high risk of bleeding after drug-eluting stent implantation; abbreviated therapy also resulted in a lower incidence of major or clinically relevant nonmajor bleeding.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Add to Collection

Article Medicine, Research & Experimental

Side-branch expansion capacity of contemporary DES platforms

Alper Oner et al.

Summary: This study evaluated the side-branch expansion behavior of contemporary drug-eluting stent platforms through in vitro bench testing. The results showed that all tested DES platforms could withstand large single-cell deformations, with designs having fewer connectors resulting in larger cell diameters following side-branch expansion. The study recommends considering the expansion capacity of side-branches in stent selection for bifurcation interventions.

EUROPEAN JOURNAL OF MEDICAL RESEARCH (2021)

Add to Collection

Article Cardiac & Cardiovascular Systems

Contemporary approaches to bifurcation stenting

Claire E. Raphael et al.

Summary: Treatment of bifurcation lesions in PCI involves understanding lesion characteristics, stent design, and therapeutic options. Provisional stenting is suitable for most cases, with consideration of a 2-stent technique in certain situations. Lesion preparation, intracoronary imaging, proximal optimization, and kissing balloon inflation are important steps in the treatment process.

JRSM CARDIOVASCULAR DISEASE (2021)

Add to Collection

Article Engineering, Biomedical

Evolution of metallic cardiovascular stent materials: A comparative study among stainless steel, magnesium and zinc

Jiayin Fu et al.

BIOMATERIALS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Stent-Related Adverse Events >1 Year After Percutaneous Coronary Intervention

Mahesh V. Madhavan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Thin Composite -Wire -Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

Rosaly A. Buiten et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

Trends and Outcomes of Restenosis After Coronary Stent Implantation in the United States

Issam D. Moussa et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)

Add to Collection

Article Multidisciplinary Sciences

Comparison of overexpansion capabilities and thrombogenicity at the side branch ostia after implantation of four different drug eluting stents

Pawel Gasior et al.

SCIENTIFIC REPORTS (2020)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Ultimaster coronary stent system: 5-year worldwide experience

Elisa Gherbesi et al.

FUTURE CARDIOLOGY (2020)

Add to Collection

Review Cardiac & Cardiovascular Systems

Stent Thrombosis After Percutaneous Coronary Intervention From Bare-Metal to the Last Generation of Drug-Eluting Stents

Alberto Polimeni et al.

CARDIOLOGY CLINICS (2020)

Add to Collection

Article Medicine, Research & Experimental

Re-endothelialisation after Synergy stent and Absorb bioresorbable vascular scaffold implantation in acute myocardial infarction: COVER-AMI study

Thibault Lhermusier et al.

TRIALS (2019)

Add to Collection

Review Medicine, General & Internal

Polymer-free versus durable polymer drug-eluting stents in patients with coronary artery disease: A meta-analysis

James J. Wu et al.

ANNALS OF MEDICINE AND SURGERY (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Biodegradable-Polymer Versus Polymer-Free Drug-Eluting Stents for the Treatment of Coronary Artery Disease

Jason Nogic et al.

CARDIOVASCULAR REVASCULARIZATION MEDICINE (2019)

Add to Collection

Article Cardiac & Cardiovascular Systems

Comparative assessment of three drug eluting stents with different platforms but with the same biodegradable polymer and the drug based on quantitative coronary angiography and optical coherence tomography at 12-month follow-up

Robert J. Gil et al.

INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

The short- and long-term outcomes of percutaneous intervention with drug-eluting stent vs bare-metal stent in saphenous vein graft disease: An updated meta-analysis of all randomized clinical trials

Babikir Kheiri et al.

CLINICAL CARDIOLOGY (2018)

Add to Collection

Meeting Abstract Cardiac & Cardiovascular Systems

Polymer-free Versus Biodegradable Polymer Drug-eluting Stents for the Treatment of Coronary Artery Disease: A Meta-analysis of Randomized Trials

Sean Tan et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Add to Collection

Review Cardiac & Cardiovascular Systems

Understanding the Coronary Bifurcation Stenting

Hyeon-Cheol Gwon

KOREAN CIRCULATION JOURNAL (2018)

Add to Collection

Review Medicine, General & Internal

Coronary Stents: History, Design, and Construction

Torrey Schmidt et al.

JOURNAL OF CLINICAL MEDICINE (2018)

Add to Collection

Article Cardiac & Cardiovascular Systems

First-in-man study of dedicated bifurcation cobalt-chromium sirolimus-eluting stent BiOSS LIM C (R) - three-month results

Robert J. Gil et al.

KARDIOLOGIA POLSKA (2018)

Add to Collection

Article Medicine, Research & Experimental

Over-expansion of drug-eluting stents in patients with left main coronary artery disease: An invivo study

Yicong Ye et al.

JOURNAL OF INTERNATIONAL MEDICAL RESEARCH (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Self-expanding STENTYS stents in daily routine use

Michal Kidawa et al.

KARDIOLOGIA POLSKA (2017)

Add to Collection

Article Multidisciplinary Sciences

A comparison of the main outcomes from BP-BES and DP-DES at five years of follow-up: A systematic review and meta-analysis

Pan Lu et al.

SCIENTIFIC REPORTS (2017)

Add to Collection

Article Cardiac & Cardiovascular Systems

Efficacy and safety of polymer-free stent versus polymer-permanent drug-eluting stent in patients with acute coronary syndrome: a meta-analysis of randomized control trials

Kang Gao et al.

BMC CARDIOVASCULAR DISORDERS (2017)

Add to Collection

Article Medicine, Research & Experimental

Development and Biological Evaluation of Inkjet Printed Drug Coatings on Intravascular Stent

Nicolaos Scoutaris et al.

MOLECULAR PHARMACEUTICS (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Three-Year Clinical Outcomes of Everolimus-Eluting Stents From the Post-Marketing Surveillance Study of Cobalt-Chromium Everolimus-Eluting Stent (XIENCE V/PROMUS) in Japan

Jiro Aoki et al.

CIRCULATION JOURNAL (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Over-expansion capacity and stent design model: An update with contemporary DES platforms

Jaryl Ng et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2016)

Add to Collection

Review Biochemistry & Molecular Biology

The Ultimaster Biodegradable-Polymer Sirolimus-Eluting Stent: An Updated Review of Clinical Evidence

Alberto Chisari et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2016)

Add to Collection

Article Cardiac & Cardiovascular Systems

Biodegradable Polymer-Based Sirolimus-Eluting Stents With Differing Elution and Absorption Kinetics The PANDA III Trial

Bo Xu et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)

Add to Collection

Review Chemistry, Multidisciplinary

Current Trends on Medical and Pharmaceutical Applications of Inkjet Printing Technology

Nicolaos Scoutaris et al.

PHARMACEUTICAL RESEARCH (2016)

Add to Collection

Editorial Material Cardiac & Cardiovascular Systems

Are at Least 12 Months of Dual Antiplatelet Therapy Needed for All Patients With Drug-Eluting Stents? Not All Patients With Drug-Eluting Stents Need at Least 12 Months of Dual Antiplatelet Therapy

Richard C. Becker et al.

CIRCULATION (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

Impact of Strut Width in Periprocedural Myocardial Infarction A Propensity-Matched Comparison Between Bioresorbable Scaffolds and the First-Generation Sirolimus-Eluting Stent

Hiroyoshi Kawamoto et al.

JACC-CARDIOVASCULAR INTERVENTIONS (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

A Randomized Trial of a Dedicated Bifurcation Stent Versus Provisional Stenting in the Treatment of Coronary Bifurcation Lesions

Philippe Genereux et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)

Add to Collection

Article Engineering, Biomedical

Effect of oxide layer modification of CoCr stent alloys on blood activation and endothelial behavior

Vincent Milleret et al.

JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS (2015)

Add to Collection

Article Multidisciplinary Sciences

Optimization of Drug Delivery by Drug-Eluting Stents

Franz Bozsak et al.

PLOS ONE (2015)

Add to Collection

Review Cardiac & Cardiovascular Systems

Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis

Hidenori Komiyama et al.

WORLD JOURNAL OF CARDIOLOGY (2015)

Add to Collection

Article Cardiac & Cardiovascular Systems

A Randomized Comparison of Platinum Chromium- Based Everolimus-Eluting Stents Versus Cobalt Chromium-Based ZotarolimusEluting Stents in All- Comers Receiving Percutaneous Coronary Intervention

Kyung Woo Park et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)

Add to Collection

Article Cardiac & Cardiovascular Systems

Comparative efficacy of 2 zotarolimus-eluting stent generations: Resolute versus endeavor stents in patients with coronary artery disease

Tomohisa Tada et al.

AMERICAN HEART JOURNAL (2013)

Add to Collection

Article Medicine, General & Internal

Coronary stents: historical development, current status and future directions

Javaid Iqbal et al.

BRITISH MEDICAL BULLETIN (2013)

Add to Collection

Article Cardiac & Cardiovascular Systems

Short- and Long-Term Outcomes With Drug-Eluting and Bare-Metal Coronary Stents A Mixed-Treatment Comparison Analysis of 117 762 Patient-Years of Follow-Up From Randomized Trials

Sripal Bangalore et al.

CIRCULATION (2012)

Add to Collection

Article Cardiac & Cardiovascular Systems

5-Year Clinical Outcomes of the ARTS II (Arterial Revascularization Therapies Study II) of the Sirolimus-Eluting Stent in the Treatment of Patients With Multivessel De Novo Coronary Artery Lesions

Patrick W. Serruys et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection

Review Cardiac & Cardiovascular Systems

Coronary Stents Looking Forward

Scot Garg et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection

Review Cardiac & Cardiovascular Systems

Coronary Stents Current Status

Scot Garg et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2010)

Add to Collection

Article Cardiac & Cardiovascular Systems

The Pharmacokinetics of Biolimus A9 After Elution From the Nobori Stent in Patients With Coronary Artery Disease: The NOBORI PK Study

Miodrag Ostojic et al.

CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS (2008)

Add to Collection

Article Cardiac & Cardiovascular Systems

A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease

Albert Schoemig et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)

Add to Collection

Article Medicine, General & Internal

Outcomes associated with drug-eluting and bare-metal stents:: a collaborative network meta-analysis

Christoph Stettler et al.

LANCET (2007)

Add to Collection

Article Cardiac & Cardiovascular Systems

Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation

Stephane Cook et al.

CIRCULATION (2007)

Add to Collection

Review Cardiac & Cardiovascular Systems

Drug-eluting stents:: an early systematic review to inform policy

RA Hill et al.

EUROPEAN HEART JOURNAL (2004)

Add to Collection

Article Cardiac & Cardiovascular Systems

Intracoronary stenting and angiographic results:: Strut thickness effect on restenosis outcome (ISAR-STEREO-2) trial

J Pache et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)

Add to Collection

Article Medicine, General & Internal

Nickel and molybdenum contact allergies in patients with coronary in-stent restenosis

R Köster et al.

LANCET (2000)

Add to Collection

Article Cardiac & Cardiovascular Systems

Ten-year clinical and angiographic follow-up of coronary wallstent

D Carrie et al.

AMERICAN JOURNAL OF CARDIOLOGY (2000)

Add to Collection

© Peeref 2019-2024. All rights reserved.